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Hypothesizing that UCP2 may influence insulin
secretion by modifying the ATP/ADP ratio within
pancreatic islets, we have investigated the expres-
sion of intraislet UCP2 gene in rats showing insulin
oversecretion (non-diabetic Zucker fa/fa obese rats,
glucose-infused Wistar rats) or insulin undersecre-
tion (fasting and mildly diabetic rats). We found that
in Zucker fa/fa obese rats, hyperinsulinemia
(1222 4-98 pmol/1 vs. 128 4- 22 pmol/1 in lean Zucker
rats) was accompanied by a significant increase in
UCP2 mRNA levels. In rat submitted to a 5 day
infusion with glucose, hyperinsulinemia (1126 4-101
pmol/l vs. 215 4- 25 pmol/1 in Wistar control rats),
coincided with an enhanced intraislet UCP2 gene
expression, whereas a 8h or a 2 day-infusion did not
induce significant changes in UCP2 mRNA expres-
sion. In rats made hypoinsulinemic and mildly
diabetic by the injection of a low dose of streptozo-
tocin, and in 4-day-fasting rats (plasma insulin
28 4- 5 pmol/1) UCP2 gene expression was sharply
decreased. A 3-day-fast was ineffective. The data
show the existence of a time-dependent correlation
between islet mRNA UCP2 and insulin that may be
interpreted as an adaptative response to prolonged
insulin excess.
Keywords: UCP2; Plasma insulin; Hyperinsulinemic rats;
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INTRODUCTION
The uncoupling protein-1 (UCP1) mediates the
proton leak in the mitochondria of the brown
adipose tissue (BAT) and promotes uncoupling
fuel oxidation from ADP phosphorylation, t1’21
This process is involved in thermoregulation
and the control of energy balance.TM Until
recently, the contribution of this pathway to
the regulation of energy expenditure and ATP
synthesis was considered as restricted to neo-
nate mammalians and rodents because BAT is
present only in small amounts in non-rodent
adult mammalians including humans.21
The discovery of homologs of UCP i.e.,
UCP2[4"51 and UCP3,
[6-81 and more recently of
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UCP4 I91 whose expression is not limited to BAT
led to re-evaluate this point of view. These new
isoforms present similar properties as UCP1 in
terms of uncoupling capacity.
This situation arises the question of the
specific role of UCPs in tissues or organs whose
function is closely dependent on the ATP/ADP
ratio. This is particularly true for insulin secre-
tion by the endocrine t-cell of the pancreas.
The stimulation of insulin release by glucose is
initiated by the closure of ATP dependent K +
channels by the ATP originating from glucose
metabolism. This results in membrane depolar-
ization and then a massive influx of Ca2+
through the opening of Ca2+ channels that
stimulates exocytosis of insulin vesicles. E11
Therefore, the ATP/ADP ratio in the l-cell is
of crucial importance in the secretory process.
Considering that UCP2 may influence insulin
secretion by modifying the ATP/ADP ratio, we
have investigated the in vivo expression of UCP2
gene in the endocrine pancreas under conditions
of over activity (non-diabetic hyperinsulinemic
Zucker fa/fa rats, glucose-infused Wistar rats)
and underactivity (fasting and mildly diabetic
rats) of the t-cell. We concentrated on UCP2
[4,11] because it has been detected in the pancreas
contrarily to the other isoforms. This study was
further stimulated by the fact that the UCP2
gene is localized to a region of rat chromosome 1
linked to glucose homeostasis in the Wistar
rat.I121 This region also includes the gene for the
sulphonylurea receptor,131 involved in insulin
secretion.[14]
MATERIALS AND METHODS
Animals
Three-month-old male Wistar rats were used.
They were maintained at 24&2C in a room
with a 12h fixed light-dark schedule. They had
free access to water and standard laboratory
chow pellets. For fasting experiments, Wistar
rats were submitted to fasting during 4 days.
Three-month-old genetically obese (fa/fa) non-
diabetic male Zucker rats 151 were used as a
model of spontaneous long-standing hyperinsu-
linemic rats. Lean (Fa/?) male Zucker rats were
used as controls. Zucker rats were housed under
the same conditions as Wistar rats.
Diabetes was induced in Wistar rats by a
single i.v. injection through the saphenous vein
of 35mg/kg body weight streptozotocin (STZ,
Sigma, St. Louis, Mo, USA) dissolved in a citrate
buffer (0.1mol/1, pH4.5). Controls were i.v.
injected with citrate buffer.
Wistar rats were submitted to saline (0.9%
NaC1) or glucose infusions. Infusions were car-
ried out with the long-term infusion technique
under unrestrained conditions as previously
described. I161 Hypertonic (30% wt/volume) glu-
cose (Chaix et Du Marais, Paris, France)
was infused at an initial rate of 50tl/min to
produce hyperglycemia around 20mmol/1. Gly-
cemia was maintained in the required ranges by
adjusting the infusion flow rate throughout the
infusion period. The infusion lasted either 8 h
(hyperglycemic-hyperinsulinemic rats: HGHI 8
h rats), or 2 days (HGHI 2 days rats), or 5 days
(HGHI 5 days rats). Rats in which glycemia did
not stay around 20mmol/1 were excluded.
Insulin and Glucose Measurements
The STZ diabetic state was characterized by the
measurement of basal plasma glucose concen-
tration and an i.v. glucose tolerance test (IVGTT)
performed two weeks after STZ injection. Glu-
cose (0.8g/kg body weight) was injected in the
postabsorptive state under pentobarbital an-
esthesia (4mg/100g body weight, i.p.-Sanofi
Sant6 Animale, Libourne, France). Blood sam-
ples were collected sequentially-before and after
glucose injection. Insulin and glucose responses
during IVGTT were calculated as the AI and the
G. The AI is the incremental plasma insulin
values integrated over a period of 30min after
the injection of glucose. The AG is theISLET UCP2 AND INSULIN STATUS 187
corresponding increase in glucose concentra-
tion. The insulinogenic index (AI/AG) repre-
sents the ratio of these two parameters.
In another group of rats, basal plasma glucose
and insulin concentrations were measured 2
days after STZ injection.
Hyperglycemic and Hyperinsulinemic
Wistar Rats
During 8 h or 2 days or 5 days infusions, plasma
glucose and insulin concentrations were mea-
sured on blood collected by tail snipping, five
times daily in glucose-infused rats and only
twice daily in saline-infused rats where these
parameters remained very stable.
Zucker and Fasted Wistar Rats
Plasma glucose and insulin concentrations were
measured on blood collected by tail snipping, in
rats in the post-absorptive state.
In situ hybridization histochemistry was used
to ascertain the presence of UCP2 mRNA within
the pancreatic islets. The protocol used was
adapted from the technique of Simmons et al. [171
as previously described, t181 A rat pancreas was
dissected out following an intracadial perfu-
sion with paraformaldehyde. The pancreas was
thereafter embedded in parrafin and sliced us-
ing a rotory microtome. The pancreas sections,
which were 5 tm thick, were mounted on slides
and hybridized with a radioactive UCP2 cRNA
probe. The specificity of the antisense riboprobe
was strongly verified by the total absence of posi-
tive signal in a pancreas section hybridized with
the sense probe.
A260/280 ratios and the 28S/18S RNA ratios
were greater than 2. Northern blot analysis was
performed using 20 tg of total RNA. Because
about 30 tg of RNA were obtained per rat, one
individual rat was used for each Northern blot
point. After blotting, nylon membranes were
successively hybridized with UCP2 and 18S
probes, labelled with (c32P)-dCTP using a
Random primed DNA labeling kit (Boehringer
Mannheim Biochemica, Germany). The cDNA
probe of UCP2 comprised the complete coding
sequence (935 bp) of the mouse UCP2 (Genbank
accession number U69135). Quantification was
performed by densitometry, using an image
analyser (Biocom, Les Ulis, France). The den-
sitometric values of the autoradiograms were
corrected for the intensities of the 18S RNA
bands.
Analytical Methods
Blood glucose was determined using a glucose
analyzer (Beckman Inc, Fullerton, CA, USA).
Insulin was measured by a radioimmunoassay
kit (Sorin, Roma, Italy). The lower limit of the
assay was 19.5pmol/1 with 6% coefficient of
variation within and between the assay.
Data Presentation and Statistical
Methods
Data are presented as means 4- SEM. The
significance of the differences between means
was evaluated by a one or two-way analysis
of variance (ANOVA). A p value < 0.05 was
considered significant.
Northern Blot Analysis
Islets were isolated by collagenase digestion
(Collagenase, Boehringer Mannheim, Man-
nheim, Germany). Islet total RNA were ex-
[19] tracted using Chomczynski’s method. The
RESULTS
Because all parameters were very similar in the
different control groups of rats (saline-infused,
non-fasting Wistar rats, citrate injected rats),
we chose to represent the results concerning188 N. KASSIS et al.
saline-infused rats as representative of the dif-
ferent Wistar control groups.
Plasma Glucose and Insulin
Concentrations
Lean and Obese Zucker Rats
In lean and obese Zucker rats, plasma glucose
concentration was similar to that of control
Wistar rats (Fig. 1). Plasma insulin was 10-fold
higher in obese Zucker rats compared to lean
Zucker rats (Fig. 1).
Glucose-infused Rats
Sustained and steady hyperglycemia of about
20mmol/1 was produced in rats infused with
glucose during 8h, or 2 days or 5 days. As a
result, insulinemia was dramatically increased
(Fig. 1). In both hyperglycemic- hyperinsuline-
mic groups, the glucose and insulin plateaus
were reached after 4h of infusion with glucose
(data not shown).
STZ Rats
Two days after STZ injection, plasma glucose
and insulin concentrations were, as compared to
controls, significantly increased and decreased,
respectively (Fig. 3).
Fifteen days after STZ injection, STZ rats were
hyperglycemic and hypoinsulinemic compared
to control Wistar rats (Figs. 2 and 3). Moreover,
glucose tolerance and glucose-induced insulin
secretion were impaired as reflected in the AG
and the AI/AG, respectively (Fig. 2). Particu-
larly, the insulin response was 3.5 fold lower
in STZ rats than in control Wistar rats.
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FIGURE A and B: Plasma glucose (A) and insulin (B) in
control rats and the different groups of hyperinsulinemic
rats. C: Northern blot analysis and quantification of the
relative levels of UCP2 mRNA in pancreatic islets in normo-
and hyperinsulinemic rats. The densitometry of autoradio-
gram was corrected for 18S RNA. Data are means + SEM of
4-7 rats. * p < 0.05 compared with Wistar control or lean
Zucker rats. HGHI: hyperglycemic and hyperinsulinemic
rats.
Fasting Wistar Rats
A 3 day fast resulted in a slight decrease in
plasma glucose concentration which was accom-
panied by a much more important fall in plasma
insulin level, which was 7-fold lower than in
control Wistar rats. Both parameters did not
evolve significantly between 3 and 4-day fasting
(Fig. 3).
In Situ Histochemistry and Histology
The presence of UCP2 within the pancreatic
islets was clearly demonstrated by in situISLET UCP2 AND INSULIN STATUS 189
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FIGURE 2 Time course of plasma glucose and insulin concentrations during an intravenous glucose tolerance test (IVGTT)
performed in Wistar control and diabetic (STZ) rats two weeks after streptozotocin or citrate injection. Values are mean +
SEM. Number of rats was 7 for Wistar control and 5 for STZ rats., p < 0.05 compared with Wistar control.
histochemistry (Fig. 4). The silver grains were
distributed over the islets suggesting that UCP2
was expressed in more than one cell type. The
presence of silver grains in areas stained in
blue/purple following aldehyde-fuchsin stain-
ing strongly suggested the presence of UCP2 in
t-cells.
UCP2 mRNA Levels
In Zucker fa/fa rats UCP2 mRNA levels were
significantly increased compared to Zucker lean
and Wistar control rats (Fig. 1). Neither a 8h nor
a 2-day infusion with glucose did not result in
any significant change in UCP2 gene expression,
whereas rats infused with glucose during 5 days
showed higher UCP2 mRNA levels than con-
trols (Fig. 1). In STZ rats studied 15 days after
the injection of the drug, UCP2 mRNA levels
were clearly decreased compared to Wistar non
diabetic rats (Fig. 2). When the rats were studied
2 days after the injection no change in islet UCP2
gene expression could be observed. Islet UCP2
gene expression was also markedly lowered
after a 4-day fast but a 3-day fast failed to alter
this parameter (Fig. 2).190 N. KASSIS et al.
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FIGURE 3 A and B: Plasma glucose (A) and insulin (B) in
control and the different groups of hypoinsulinemic rats. The
value for 15 day-STZ rats is the value at time point 0 of the
intravenous glucose tolerance test. C: Northern blot analysis
and quantification of the relative levels of UCP2 mRNA in
pancreatic islets in normo- and hyporinsulinemic rats. The
densitometry of autoradiogram was corrected for 18S RNA.
Data are means 4-SEM of 4-7 rats., p < 0.05 significantly
different from controls Wistar rats. STZ rats: Hypoinsuline-
mic and mildly diabetic rats.
DISCUSSION
Both in situ hybridization and Northern blot
analysis clearly indicate the expression of UCP2
in rat pancreatic islets in agreement with studies
from other groups showing UCP2 gene expres-
sion in the whole pancreas
[41 and pancreatic
islets [11"2] in humans and rodents. The data
obtained in our study provide evidence for a
correlation in vivo between UCP2 gene expres-
sion in pancreatic islets and the insulin status in
Zucker and Wistar rats.
UCP2 mRNA levels were clearly increased in
non-diabetic fa/fa obese Zucker rats which are
highly hyperinsulinemic and normoglycemic.
Hyperinsulinemia associated with insulin resis-
tance has been long recognized as one of the
main characteristics of these rats. [151 Oversecre-
tion of insulin in response to many secretago-
gues is present very early, before weaning i.e.,
when obesity is not yet detectable.21]
To confirm and precise the relationship
between UCP2 mRNA and insulin release in
vivo, we infused Wistar rats with glucose to
provoke hyperinsulinemia and the infusion rate
was adjusted to reach plasma insulin levels
similar to those of obese fa/fa Zucker rats. When
glucose infusion and consequently hyperinsuli-
nemia lasted 5 days, an increase in UCP2 mRNA
was observed. On the contrary, the increase in
plasma insulin concentration resulting from a 8h
or even a 2 day infusion with glucose, was not
accompanied by significant changes in islet
UCP2 mRNA. The fact that insulin oversecretion
precedes the increase in islet UCP2 mRNA
suggests that the increase in UCP2 gene expres-
sion could be a consequence of insulin over-
secretion but cannot be an inducer of increased
pancreatic islet function. Moreover, combined
with the fact that hyperinsulinemia was estab-
lished for a very long time in 3 month-old
fa/fa obese Zucker rats used in our study,
this suggests that, apart plasma insulin level,
the duration of insulin oversecretion is of cucial
importance in islet UCP2 gene expression.
If the level of UCP2 mRNA in pancreatic islets
is correlated with islet function it could logically
be expected that pancreatic islet underfunction
is accompanied by UCP2 mRNA underexpres-
sion. To assess this point we used two models.ISLET UCP2 AND INSULIN STATUS 191
FIGURE 4 Panel A. Pancreatic islet hybridized with an antisense riboprobe complementary to the rat UCP2 mRNA. UCP2
mRNA is revealed by silver grains on a hematoxylin and eosin stained section. Panel B. Fuchsin staining of a pancreatic islet
from a tissue section consecutive to the section seen in A. The t-cells granules are stained in blue/purple whereas the c-cells
granules are stained in orange. Magnification 100 x. (See Color Plate I).
In the first model, Wistar rats were rendered
mildly diabetic by the injection of a low dose of
streptozotocin. Although basal insulin was only
slightly decreased in STZ rats compared to
controls, the very low insulin response to
glucose loading strongly suggests that postpran-
dial insulin secretion was greatly altered and
therefore pancreatic islet activity was, as a
whole, much lower than normal.As a result,
UCP2 mRNA was sharply decreased. We found
no change in islet UCP2 mRNA concentration 2
days after STZ injection, thus indicating that
STZ per se could not influence UCP2 mRNA
expression. A recent study by Kageyama
et al., showed an increased level of UCP2 mRNA
in muscles of rats with strepozotocin-induced
diabetes.241 It is difficult to compare the data
of this study and those of our own study be-
cause of the difference in the severity of experi-
mental diabetes. However, this suggests that the
regulation of UCP2 gene expression is tissue-
specific. A second way to lower pancreatic islet
function was to submit rats to fasting. As
expected, fasting resulted in a sharp decrease in192 N. KASSIS et al.
plasma insulin concentration whatever its dura-
tion but UCP2 mRNA was down-regulated
only in 4-day fasting rats. This is a further argu-
ment in favor of the time-dependency of the
effect of pancreatic islet activity on UCP2 gene
expression. This time-dependency suggests
that the influence of f-cell function on islet
UCP2 gene expression may require undirect
mechanisms.
In rats, differential effects of fasting on UCP2
mRNA could be observed according to the tis-
sue studied. UCP2 was up-regulated by a 48h
fasting or food deprivation in skeletal muscle
but neither in heart nor in brown adipose tissue
(BAT) where it was unchanged. I271 Long-term
food deprivation decreased UCP2 mRNA in
interscapular BAT. I2sl Taken together with
the data from the present study, this tissue
specificity gene expression argues for a spe-
cific regulation and role of UCP2 in pancreatic
islets.
The main conclusion of this study is the
existence of a quantitative and apparently
time-dependent correlation between islet mRNA
UCP2 and islet function. If a specific role is
ascribed to islet UCP2, this correlation may be
interpreted as an adaptative response to pro-
longed insulin excess. In situations of pancreatic
islet overfunction, such as in obesity, UCP2
expression would be increased and in turn that
would limit insulin secretion by lowering ATP
concentration within the t-cell. In a recent study,
Wang et al. [29] induced UCP2 gene overexpres-
sion in islets of ZDF rats. They observed that this
overexpression resulted in a decrease in ATP
content within the islet and a concomitant
restoration of glucose-induced insulin secretion.
According to the authors conclusion, the data
could be intrepreted in the following way: in
ZDF rats, intraislet high ATP levels would
permanently close K +-ATP channels and finally
will be responsible for the chronic basal insulin
secretion observed in this model, t31 Conse-
quently, the t-cell would be insensitive to a
further stimulation by glucose. The restoration
of the insulin response to glucose by high UCP2
expression could therefore be explained by its
lowering effect on ATP concentration which
will abolish the permanent closure of K +-ATP
channels and the resulting insulin oversecretion.
This cascade of events will allow the t-cell to be
normally sensitive to glucose. Another recent
study showing a clear inhibition of the insulin
response to glucose in rat islets overexpressing
UCP2 also agrees with our hypothesis. I31
Altogether the data from both studies fit to our
own data since they may ascribe to intraislet
UCP2 a role of regulator of insulin secretion and
reinforce the notion of a relationship between
intraislet UCP2 expression and insulin secretion.
Further experiments are required to explore the
intracellular signal(s) linking UCP2 gene expres-
sion and insulin secretion.
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